BioAdvance - Apply for Funding
Apply For Funding

Apply for Funding

Companies and investigators may submit materials for funding consideration at any time by emailing an executive summary, investor presentation, BFTP applications (submitted within the last six months) or business plan to Marnie McCoy the BioAdvance Program Director at (mmccoy@bioadvance.com). 

If you are an investigator from an academic institution please email a summary of the technology, a list of the intellectual property and an outline of intended use of funds.  We ask that you notify your technology transfer office that you are submitting materials to BioAdvance.

For those interested in applying for the Entrepreneur Start-up Kit please contact Marnie McCoy at (mmccoy@bioadvance.com) for further information.

Please note that whether submitting an executive summary, investor presentation, BFTP application or business plan there is information that BioAdvance will want to assess during its review of the opportunity.  This information includes:

  • Technical Background and Plan
  • Commercial Opportunity
  • Intellectual Property
  • Management Team
  • Budget and Use of Funds

 For further details regarding the types of information BioAdvance looks for under each of these topics, please see the "Request for Proposals" document

If content addressing these topics are not adequately covered in the initial materials, BioAdvance will request additional documentation to address these issues during the review process.  We will work with each applicant on a case-by-case basis if there is missing information. The more complete the information you submit the sooner we can make a preliminary determination. 

Further information regarding the BioAdvance review process, eligibility requirements and investment terms can be found in the "Request for Proposals" document.  In addition, we encourage all applicants to review the "BioAdvance Funding Workshop Presentation" which is particularly useful in understanding how BioAdvance thinks and the typical pitfalls that we encountered in our review of investment opportunities.